Evaluation of drug risk during pregnancy: Methodology and risk management;EVALUATION DU RISQUE MEDICAMENTEUX CHEZ LA FEMME ENCEINTE: METHODOLOGIE D'EVALUATION ET GESTION DU RISQUE

Therapie

Volumn 52, Issue 4, 1997, Pages 307-311

  Elefant E ^a   Sainte Croix, A ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b Pharmacovigilance   (France)

Author keywords

Drugs; Pregnancy

Indexed keywords

CONFERENCE PAPER; CONGENITAL MALFORMATION; DRUG MONITORING; DRUG SAFETY; DRUG SCREENING; FEMALE; FETUS; FETUS RISK; HUMAN; LEGAL ASPECT; PREGNANCY; PRIORITY JOURNAL; REGISTRATION; RISK; RISK BENEFIT ANALYSIS; TERATOGENICITY; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG THERAPY; FORECASTING; NEWBORN; PREGNANCY COMPLICATION; RISK ASSESSMENT; RISK MANAGEMENT;

ABNORMALITIES, DRUG-INDUCED; DRUG EVALUATION; DRUG THERAPY; FEMALE; FORECASTING; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; RISK ASSESSMENT; RISK MANAGEMENT;

EID: 0031174765     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Gobet JC, Petit G, Rotivel Y et al. Consommation médicamenteuse de la femme enceinte: à propos d'une enquête rétrospective chez 1 000 femmes ayant accouché dans les maternités lyonnaises. Lyon Med 1980; 244, 20: 403-409.
2. Rubin PC, Craig GF, Gavin K et al. Prospective survey of use of therapeutic drugs, alcohol, and cigarettes during pregnancy. BMJ 1986; 292: 81-83.
3. Piper JM, Baum C, Kennedy DL. Prescription drug use before and during pregnancy in a Medicaid population. Am J Obstet Gynecol 1987; 157: 148-156.
4. Buitendijk S, Bracken MB. Medication in early pregnancy: prevalence of use and relationship to maternal charasteristics. Am J Obstet Gynecol 1991; 165: 33-40.
5. Berthier M, Bonneau D, Perault MC et al. Medications exposure during pregnancy. Therapie 1993; 48: 43-46.
6. Eléfant E, Boyer M, Boyer P et al. Teratogenic agent Information centre: fifteen years of counseling and pregnancy follow-up. Teratology 1992; 46: 35-44.
7. Veronese L, Damase-Michel C, Montastruc JL. Pharmacovigilance de la grossesse: bilan du centre Midi-Pyrénées. Therapie 1994; 49: 473-475.
8. Chiffoleau A, Veyrac G, Baudot S, Larousse C. Bilan de 2 années du suivi des questions 'Médicaments-Grossesse' au CRPV de Nantes entre mars 1992 et mars 1994. Therapie 1995; 50: 429-438.
9. Eléfant E, Roux C. Evaluation du risque et information sur la tératogenèse médicamenteuse. Therapie 1985; 40: 297-300.
10. Roux C, Migné G, Mulliez N, Youssef S. Fréquence des malformations à la naissance: étude d'une maternité parisienne pendant 5 ans. J Gyn Obst Biol Reprod 1982; 11: 215-226.
11. EUROCAT (European Registration of Congenital Anomalies). Surveillance of Congenital Anomalies in Europe 1980-1992. Report 6. Brussels: Eurocat Working Group/ Institute of Hygiene and Epidemiology, 1995.
12. Wilson JG. Embryotoxicity of drugs in man. In: Wilson JG, Fraser FC, eds. Handbook of Teratology. New York: Plenum Press, 1977, Vol. I: 309-355.
13. Eléfant E, Boyer P, Roux C. Tératologie. Encycl Med Chir Obstétrique 1986; 5116 A10, 3-1986.
14. Schilliger P, Bavoux F, Eléfant E. Attention aux médicaments en fin de grossesse. Rev Prescr 1991; 110: 423-429.
15. Bavoux F. Toxicité fœtale des anti-inflammatoires non stéroïdiens. Presse Med 1992; 21: 1909-1912.
16. Registre France/Centre-Est de malformations congénitales. Evolution sur 15 ans: 1979-1993. Lyon: Institut Européen des Génomutations, 1996.
17. Vial T, Maguin V, Pham E, Descotes J. Tératovigilance: méthodologie de suivi des appels. Therapie 1989; 44: 453-455.
18. Garbis JM, Robert E, Peters PWJ. Experience of two Teratology Information Services in Europe. Teratology 1990; 42: 629-634.
19. Guihlem D, Castex V, Soubrié C. Exploitation possible d'un centre de pharmacovigilance concernant le risque tératogène. Therapie 1993; 48: 47-49.
20. Mastroiacovo P, Serafini M, Pegano M et al. The 'Telefono Rosso': a service for the prevention of birth defects and for the evaluation of teratogenic risk. Ann 1st Super Sanita 1993; 29: 115-120.
21. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Heinonen OP. Littleton: Publishing Science group, 1977.